Oramed Pharmaceuticals (ORMP) Leases (2022 - 2025)
Oramed Pharmaceuticals (ORMP) has disclosed Leases for 3 consecutive years, with $486000.0 as the latest value for Q3 2024.
- For the quarter ending Q3 2024, Leases fell 36.72% year-over-year to $486000.0, compared with a TTM value of $486000.0 through Sep 2024, down 36.72%, and an annual FY2023 reading of $694000.0, down 29.69% over the prior year.
- Leases was $486000.0 for Q3 2024 at Oramed Pharmaceuticals, down from $566000.0 in the prior quarter.
- Across five years, Leases topped out at $1.1 million in Q1 2022 and bottomed at $486000.0 in Q3 2024.
- Average Leases over 3 years is $823181.8, with a median of $842000.0 recorded in 2023.
- The sharpest move saw Leases dropped 17.42% in 2023, then plummeted 36.72% in 2024.
- Year by year, Leases stood at $987000.0 in 2022, then decreased by 29.69% to $694000.0 in 2023, then dropped by 29.97% to $486000.0 in 2024.
- Business Quant data shows Leases for ORMP at $486000.0 in Q3 2024, $566000.0 in Q2 2024, and $608000.0 in Q1 2024.